We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+13.7%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$17.9B
AUM Growth
+$1.58B
Cap. Flow
-$417M
Cap. Flow %
-2.33%
Top 10 Hldgs %
32.43%
Holding
346
New
7
Increased
114
Reduced
151
Closed
7

Top Buys

Rank Stock Value
1
UPS icon
United Parcel Service
UPS
+$47.5M
2
MDT icon
Medtronic
MDT
+$28.4M
3
BBY icon
Best Buy
BBY
+$15.7M
4
O icon
Realty Income
O
+$12.9M
5
MDLZ icon
Mondelez International
MDLZ
+$12.3M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$62.4M
2
AMGN icon
Amgen
AMGN
+$60M
3
LMT icon
Lockheed Martin
LMT
+$49.3M
4
CCI icon
Crown Castle
CCI
+$25.7M
5
MSFT icon
Microsoft
MSFT
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 25.23%
2 Financials 14.96%
3 Healthcare 13.3%
4 Consumer Staples 9.86%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOX icon
101
Amdocs
DOX
$6.22B
$14.3M 0.08%
191,261
+35,876
+23% +$2.69M
BRK.B icon
102
Berkshire Hathaway Class B
BRK.B
$1.13T
$14.3M 0.08%
47,754
-78
-0.2% -$22.3K
FAST icon
103
Fastenal
FAST
$59.5B
$14.2M 0.08%
443,750
-1,660
-0.4% -$48.9K
SIMO icon
104
Silicon Motion
SIMO
$8.68B
$14.2M 0.08%
149,280
+10,745
+8% +$810K
LOW icon
105
Lowe's Companies
LOW
$125B
$13.8M 0.08%
53,441
-267
-0.5% -$63.5K
PRGS icon
106
Progress Software
PRGS
$1.76B
$13.4M 0.07%
277,473
-42,125
-13% -$2.1M
RMD icon
107
ResMed
RMD
$30.7B
$12.9M 0.07%
49,646
-1,392
-3% -$361K
ADC icon
108
Agree Realty
ADC
$9.41B
$12.8M 0.07%
180,064
+22,600
+14% +$1.57M
MANT
109
DELISTED
Mantech International Corp
MANT
$12.6M 0.07%
172,539
+37,412
+28% +$2.85M
CE icon
110
Celanese
CE
$4.82B
$12.4M 0.07%
73,916
+3,777
+5% +$615K
SMG icon
111
ScottsMiracle-Gro
SMG
$3.66B
$12.2M 0.07%
76,076
+15,347
+25% +$2.37M
DOV icon
112
Dover
DOV
$28.4B
$12.2M 0.07%
67,086
-739
-1% -$125K
AVY icon
113
Avery Dennison
AVY
$13.4B
$11.9M 0.07%
55,050
+2,740
+5% +$586K
XLNX
114
DELISTED
Xilinx Inc
XLNX
$11.8M 0.07%
55,698
-1,089
-2% -$215K
MZTI
115
The Marzetti Company
MZTI
$3.11B
$11.7M 0.07%
70,849
+14,350
+25% +$2.35M
NVS icon
116
Novartis
NVS
$297B
$11.5M 0.06%
131,981
-7,603
-5% -$631K
CPT icon
117
Camden Property Trust
CPT
$11.3B
$11.4M 0.06%
64,052
NTAP icon
118
NetApp
NTAP
$37.2B
$11.2M 0.06%
122,270
+8,522
+7% +$768K
LMAT icon
119
LeMaitre Vascular
LMAT
$1.86B
$11.1M 0.06%
220,236
+13,294
+6% +$687K
BX icon
120
Blackstone
BX
$110B
$10.9M 0.06%
84,625
+25
+0% +$3.33K
TRNO icon
121
Terreno Realty
TRNO
$7.49B
$10.8M 0.06%
126,819
+20,746
+20% +$1.56M
HAS icon
122
Hasbro
HAS
$13.2B
$10.2M 0.06%
100,492
+5,335
+6% +$512K
ZTS icon
123
Zoetis
ZTS
$30B
$9.99M 0.06%
40,925
+4,225
+12% +$925K
BCPC
124
Balchem Corp
BCPC
$5.72B
$9.94M 0.06%
58,953
-193
-0.3% -$31K
GOOG icon
125
Alphabet (Google) Class C
GOOG
$4.32T
$9.64M 0.05%
66,660
-380
-0.6% -$54.9K

Similar funds

Bahl & Gaynor's Q4 2021 Portfolio in Review

As of Q4 2021, Bahl & Gaynor held 346 positions worth $17.9B, up 9.7% from $16.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4%. Bahl & Gaynor opened 7 new positions and exited 7, leaving the 346-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2021 buy was Perrigo: 102,203 shares worth $3.98M.
  • Bahl & Gaynor added most to United Parcel Service in Q4 2021, an estimated $47.5M increase.
  • Bahl & Gaynor's biggest Q4 2021 reduction was Honeywell, cutting an estimated $62.4M.
  • Bahl & Gaynor fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $5.63M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $17.9B portfolio in Q4 2021.
  • Bahl & Gaynor opened 7 new positions and closed 7 in Q4 2021.
  • Bahl & Gaynor's portfolio value rose 9.7% quarter-over-quarter to $17.9B.

Based on Bahl & Gaynor's 13F filing for Q4 2021, filed 10 Feb 2022.